Clinical
Diabetic ketoacidosis and mortality
In Clinical
Let’s get clinical. Follow the links below to find out more about the latest clinical insight in community pharmacy.Bookmark
Record learning outcomes
Recurrent diabetic ketoacidosis (DKA) is associated with “a substantially elevated risk of deathâ€, says Diabetologia.
Researchers at the Royal Infirmary of Edinburgh found that 5.2 per cent of those with a single DKA admission died during follow-up, which lasted a median of 4.1 years. Mortality rose to 13.5 per cent in those with two to five DKA admissions over a median of 3.7 years, while 23.4 per cent of those with more than five admissions died over a 2.4 year follow-up.
(DOI 10.1007/ s00125-016-4034-0)